Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

By sjmartinez • March 12, 2024

Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918. Cancers (Basel). 2024 Mar 1;16(5):1026. doi: 10.3390/cancers16051026. Erratum for: Cancers (Basel). 2020 Jul 16;12(7): PMID: 38473438.

Tags: Endocrinology, General Internal Medicine, King Drew Med Ctr, Publications

Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient Perspective

Agrawal N, Kanin M, Binder HL, Havard A, Grock S. Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient[...]

Developing and Evaluating a Natural Language Processing Algorithm to Detect Insulin Pump and Continuous Glucose Monitor Use in Electronic Health Records of Patients with Type 1 Diabetes

Everett E, Tiu RA, Zhu B, Feng J, Jackson N, Graham J, Ipp E, Mathioudakis N, Bui AAT, Moin T. Developing and Evaluating a Natural[...]

A Case of Warthin-Like Variant of Papillary Thyroid Cancer

Chow A, Laklouk I. A Case of Warthin-Like Variant of Papillary Thyroid Cancer. Cureus. 2025 Aug 28;17(8):e91182. doi: 10.7759/cureus.91182. PMID: 41018445; PMCID: PMC12476197.